The Current Ratio as of December 2025 (TTM) for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) is 2.08

According to Shenzhen Neptunus Interlong Bio-technique Company Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.08. This represents a change of -6.71% compared to the average of 2.23 of the last 4 quarters.

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Historical Current Ratio (quarterly & annually)

How has 8329.HK Current Ratio performed in the past?

The mean historical Current Ratio of Shenzhen Neptunus Interlong Bio-technique Company Limited over the last ten years is 2.73. The current 2.08 Current Ratio has changed 7.51% with respect to the historical average. Over the past ten years (40 quarters), 8329.HK's Current Ratio was at its highest in in the December 2018 quarter at 4.04. The Current Ratio was at its lowest in in the September 2015 quarter at 0.

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Shenzhen Neptunus Interlong Bio-technique Company Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Average Current Ratio

How has 8329.HK Current Ratio performed in the past?

The current Current Ratio of Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Current Ratio vs. Peers

How is 8329.HK’s Current Ratio compared to its peers?

Shenzhen Neptunus Interlong Bio-technique Company Limited’s Current Ratio is less than Extrawell Pharmaceutical Holdings Limited (21.91), less than Huakang Biomedical Holdings Company Limited (4.00), greater than Tianda Pharmaceuticals Limited (0.86), greater than Bamboos Health Care Holdings Limited (0.92), greater than Tycoon Group Holdings Limited (1.32), greater than Tai United Holdings Limited (0.04), greater than PuraPharm Corporation Limited (0.52), less than China Health Group Inc. (3.23), greater than Good Fellow Healthcare Holdings Limited (0.52), greater than Regent Pacific Group Limited (0.15),

Build a custom stock screener for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Neptunus Interlong Bio-technique Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Neptunus Interlong Bio-technique Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.